Why Are Men More Vulnerable to COVID-19? Research Is Gradually Uncovering the Truth

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health,…

Read more

To Do the Therapy & MRI Follow-up or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients

Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board…

Read more

To Do the Surgery or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices…

Read more

Antibody Testing May Not Give You the Back-to-Work Safety Pass as Expected

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With a phased reopening starting..

Read more

Multi-functional Antibodies: New Immunotherapy for Advanced Cancer

Cancer is the second leading cause of death worldwide, with 18 million new cases in 2018 and 9.6 million deaths..

Read more